This inventor holds 1 USPTO granted patent. Top assignee: Equispharm Co., Ltd. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: The Innovative Contributions of Jee-Young Lee
Introduction
Jee-Young Lee is a prominent inventor based in Ahnyang-si, South Korea. She has made significant strides in the field of pharmaceuticals, particularly with her work on fumagillol derivatives. Her innovative approach has the potential to impact various medical conditions, including cancer and inflammatory diseases.
Latest Patents
Jee-Young Lee holds a patent for "Fumagillol derivatives and preparing method thereof." This patent describes a fumagillol compound that serves as an angiogenesis inhibiting agent. It demonstrates a superior angiogenesis inhibitory effect with reduced toxicity. Additionally, it functions as a cancer metastasis inhibitor and a therapeutic agent for various inflammatory diseases, such as rheumatic disease, psoriasis, and diabetic retinopathy.
Career Highlights
Throughout her career, Jee-Young Lee has been associated with Equispharm Co., Ltd. Her work at this company has allowed her to focus on developing innovative solutions in the pharmaceutical industry. Her contributions have been recognized for their potential to improve patient outcomes and advance medical research.
Collaborations
Jee-Young Lee has collaborated with notable colleagues, including Cheol-Kyu Han and Jeong-Hyeok Yoon. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Jee-Young Lee's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical treatments and therapies.